Efficacy and safety of amlodipine used as add-on therapy in moderately to severely hypertensive patients not adequately controlled by olmesartan medoxomil 20 mg monotherapy
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Amlodipine (Primary) ; Olmesartan medoxomil (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Europe
- 05 Jun 2009 Results were published in Clinical Drug Investigation, Volume 29, Number 7, 5 June 2009.
- 29 Oct 2005 New trial record.